Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes | Zendy

Nadeem Khan | Zendy; Fazeel M. Siddiqui | Zendy; Joshua N. Goldstein | Zendy; Margueritte Cox | Zendy; Ying Xian | Zendy; Roland Matsouaka | Zendy; Paul A. Heidenreich | Zendy; Eric D. Peterson | Zendy; Deepak L. Bhatt | Zendy; Gregg C. Fonarow | Zendy; Lee H. Schwamm | Zendy; Eric E. Smith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes

Author(s) -

Nadeem Khan,

Fazeel M. Siddiqui,

Joshua N. Goldstein,

Margueritte Cox,

Ying Xian,

Roland Matsouaka,

Paul A. Heidenreich,

Eric D. Peterson,

Deepak L. Bhatt,

Gregg C. Fonarow,

Lee H. Schwamm,

Eric E. Smith

Publication year - 2017

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.117.016290

Subject(s) - medicine , intracerebral hemorrhage , stroke (engine) , clopidogrel , ischemic stroke , aspirin , subarachnoid hemorrhage , ischemia , mechanical engineering , engineering

Although the use of antiplatelet therapy (APT) is associated with the risk of intracerebral hemorrhage (ICH), there are limited data on prestroke APT and outcomes, particularly among patients on combination APT (CAPT). We hypothesized that the previous use of antiplatelet agents is associated with increased mortality in ICH.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research